Regenxbio (RGNX) Other Working Capital Changes (2014 - 2025)
Regenxbio (RGNX) posted quarterly Other Working Capital Changes of -$14.2 million for Q4 2025, down 48903.45% year-over-year from N/an in Q4 2024, and down 242.37% quarter-over-quarter from $10.0 million in Q3 2025.
Regenxbio (RGNX) Other Working Capital Changes (2014 - 2025) Analysis & Trends
Regenxbio's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at $3.3 million for Q4 2018.
- In Q4 2018, Other Working Capital Changes changed N/A year-over-year to $3.3 million; the TTM figure through Dec 2018 stood at $3.3 million (changed N/A YoY), while the FY2018 annual figure was $3.9 million, changed N/A from the prior year.
- Other Working Capital Changes for Q4 2018 stood at $3.3 million, up from -$35000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $39.8 million in Q1 2025, with the low at -$44.2 million in Q2 2025.
- The 5-year median for Other Working Capital Changes is -$82000.0 (2024), against an average of $447750.0.
- Peak annual rise in Other Working Capital Changes reached 29559.26% in 2025, while the deepest fall reached 48903.45% in 2025.
- Regenxbio's Other Working Capital Changes stood at -$15000.0 in 2014, then soared by 66.67% to -$5000.0 in 2015, then plunged by 600.0% to -$35000.0 in 2016, then surged by 9622.86% to $3.3 million in 2018.
- Business Quant data shows RGNX's Other Working Capital Changes at $3.3 million in Q4 2018, -$35000.0 in Q2 2016, and -$92000.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Regenxbio | 583.35 Mn | 477.83 Mn | 106.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14.21 Mn |
| Dec 31, 2025 | -14.21 Mn |
| Dec 31, 2025 | -14.21 Mn |
| Sep 30, 2025 | 9.98 Mn |
| Sep 30, 2025 | 9.98 Mn |
| Sep 30, 2025 | 9.98 Mn |
| Jun 30, 2025 | -44.17 Mn |
| Jun 30, 2025 | -44.17 Mn |
| Jun 30, 2025 | -44.17 Mn |
| Mar 31, 2025 | 39.77 Mn |
| Mar 31, 2025 | 39.77 Mn |
| Mar 31, 2025 | 39.77 Mn |
| Dec 31, 2024 | -29,000.00 |
| Dec 31, 2024 | -29,000.00 |
| Dec 31, 2024 | -29,000.00 |
| Sep 30, 2024 | 4.02 Mn |
| Sep 30, 2024 | 4.02 Mn |
| Sep 30, 2024 | 4.02 Mn |
| Jun 30, 2024 | -3.89 Mn |
| Jun 30, 2024 | -3.89 Mn |